Kongressthemen
Returning in March, the 3rd Bacteriophage Therapy Summit will discuss the characterization, pre-clinical and clinical development, formulation and manufacturing, regulation and the market delivery, this is the end-to-end specialised virtual meeting for you to translate your bacteriophage research into targeted therapeutics that demonstrate clinically significant results.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Sailaja Puttagunta, CMO, BiomX, Steven Theriault, CEO and CSO, Cytophage, Xavier Duportet, Co-Founder and CEO, Eligo Bioscience, Cara Fiore, Microbiologist, FDA, Office of Vaccines Research and Review and more.
https://go.evvnt.com/709133-2?pid=4832
Herr Customer Services
KategorienAllgemeinmedizin
